PERMA FIX ENVIRONMENTAL SERVICES INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that PERMA FIX ENVIRONMENTAL SERVICES INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $642.0K | Mar 24, 2026 |
| FY2022 | Dec 31, 2022 | $60.03M | Mar 23, 2023 |
| FY2022 | Dec 31, 2021 | $60.81M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $96.58M | Apr 6, 2022 |
| FY2020 | Dec 31, 2019 | $59.99M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $35.94M | Mar 20, 2020 |
| FY2017 | Dec 31, 2017 | $6.31M | Mar 16, 2018 |
| FY2017 | Dec 31, 2016 | $4.42M | Mar 16, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $61.67M | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | $59.12M | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | $89.74M | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | $70.60M | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | $72.19M | Mar 23, 2023 |
| FY2021 | Sep 30, 2021 | $1.29M | Apr 6, 2022 |
| FY2021 | Dec 31, 2020 | $105.43M | Apr 6, 2022 |
| FY2020 | Dec 31, 2019 | $73.46M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $49.54M | Mar 20, 2020 |
| FY2018 | Dec 31, 2017 | $49.77M | Apr 1, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $49.77M | Mar 16, 2018 |
| FY2017 | Dec 31, 2016 | $51.22M | Mar 16, 2018 |
| FY2016 | Dec 31, 2015 | $62.38M | Mar 24, 2017 |
| FY2015 | Dec 31, 2014 | $57.07M | Mar 24, 2016 |
| FY2013 | Dec 31, 2013 | $12.73M | Apr 15, 2014 |
| FY2013 | Sep 30, 2013 | $19.07M | Apr 15, 2014 |
| FY2013 | Jun 30, 2013 | $22.78M | Apr 15, 2014 |
| FY2013 | Mar 31, 2013 | $19.83M | Apr 15, 2014 |
| FY2013 | Dec 31, 2012 | $26.68M | Apr 15, 2014 |
| FY2013 | Sep 30, 2012 | $29.19M | Apr 15, 2014 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.97M | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | $2.0K | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | $16.37M | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | $9.61M | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | $6.82M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $15.89M | Apr 6, 2022 |
| FY2020 | Dec 31, 2019 | $15.58M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $8.46M | Mar 20, 2020 |
| FY2018 | Dec 31, 2017 | $8.62M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $7.08M | Mar 16, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($13.78M) | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | ($19.98M) | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | $485.0K | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | ($3.82M) | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | $835.0K | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $2.86M | Apr 6, 2022 |
| FY2020 | Dec 31, 2019 | $2.32M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | ($1.42M) | Mar 20, 2020 |
| FY2018 | Dec 31, 2017 | ($3.68M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($13.41M) | Mar 16, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($11.74M) | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | ($15.68M) | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | $756.0K | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | ($5.40M) | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | ($6.77M) | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $3.33M | Apr 6, 2022 |
| FY2020 | Dec 31, 2019 | $2.97M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | ($3.60M) | Mar 20, 2020 |
| FY2018 | Dec 31, 2017 | ($4.74M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($15.79M) | Mar 16, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.29M | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | $1.17M | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | $561.0K | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | $336.0K | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | $746.0K | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $762.0K | Apr 6, 2022 |
| FY2020 | Dec 31, 2019 | $750.0K | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $1.37M | Mar 20, 2020 |
| FY2018 | Dec 31, 2017 | $1.60M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $2.05M | Mar 16, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.42M | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | $14.49M | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | $14.98M | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | $14.65M | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | $12.85M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $11.77M | Apr 6, 2022 |
| FY2020 | Dec 31, 2019 | $11.86M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $10.74M | Mar 20, 2020 |
| FY2018 | Dec 31, 2017 | $11.10M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $10.72M | Mar 16, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($10.75M) | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | ($14.74M) | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | $6.47M | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | ($553.0K) | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | ($6.84M) | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $7.37M | Apr 6, 2022 |
| FY2020 | Dec 31, 2019 | ($4.68M) | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $1.96M | Mar 20, 2020 |
| FY2018 | Dec 31, 2017 | $442.0K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $104.0K | Mar 16, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.71M | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | $3.41M | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | $1.71M | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | $1.02M | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | $1.58M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $1.72M | Apr 6, 2022 |
| FY2020 | Dec 31, 2019 | $1.54M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $1.43M | Mar 20, 2020 |
| FY2018 | Dec 31, 2017 | $439.0K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $436.0K | Mar 16, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $88.03M | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | $97.25M | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | $78.75M | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | $70.90M | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | $77.30M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $78.92M | Apr 6, 2022 |
| FY2020 | Dec 31, 2019 | $66.52M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $57.44M | Mar 20, 2020 |
| FY2018 | Dec 31, 2017 | $59.54M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $65.34M | Mar 16, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $37.90M | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | $34.86M | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | $39.37M | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | $33.37M | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | $36.72M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $46.47M | Apr 6, 2022 |
| FY2020 | Dec 31, 2019 | $37.28M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $31.31M | Mar 20, 2020 |
| FY2018 | Dec 31, 2017 | $31.09M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $33.18M | Mar 16, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $50.14M | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | $62.39M | Mar 24, 2026 |
| FY2025 | Dec 31, 2023 | $39.38M | Mar 24, 2026 |
| FY2024 | Dec 31, 2022 | $37.53M | Mar 13, 2025 |
| FY2021 | Dec 31, 2021 | $40.58M | Apr 6, 2022 |
| FY2021 | Dec 31, 2020 | $34.19M | Apr 6, 2022 |
| FY2020 | Dec 31, 2019 | $30.86M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $27.63M | Mar 20, 2020 |
| FY2018 | Dec 31, 2017 | $28.34M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $31.60M | Mar 16, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | $0 | Mar 24, 2016 |
| FY2015 | Dec 31, 2014 | $0 | Mar 24, 2016 |
| FY2014 | Dec 31, 2013 | $1.33M | Mar 31, 2015 |
| FY2014 | Dec 31, 2012 | $29.19M | Mar 31, 2015 |
| FY2013 | Dec 31, 2011 | $29.19M | Apr 15, 2014 |
| FY2012 | Dec 31, 2010 | $15.33M | Dec 12, 2013 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($110.71M) | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | ($96.93M) | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | ($76.95M) | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | ($77.44M) | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | ($73.62M) | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | ($74.46M) | Apr 6, 2022 |
| FY2020 | Dec 31, 2019 | ($77.32M) | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | ($79.63M) | Mar 20, 2020 |
| FY2018 | Jan 2, 2018 | ($78.21M) | Apr 1, 2019 |
| FY2018 | Dec 31, 2017 | ($77.89M) | Apr 1, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $1.87M | Mar 23, 2023 |
| FY2022 | Dec 31, 2021 | $4.44M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $7.92M | Apr 6, 2022 |
| FY2020 | Dec 31, 2019 | $390.0K | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $810.0K | Mar 20, 2020 |
| FY2018 | Dec 31, 2017 | $1.06M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $163.0K | Mar 16, 2018 |
| FY2017 | Dec 31, 2015 | $1.44M | Mar 16, 2018 |
| FY2016 | Dec 31, 2014 | $3.68M | Mar 24, 2017 |
| FY2015 | Dec 31, 2013 | $333.0K | Mar 24, 2016 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.87M | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | $2.32M | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | $2.75M | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | $1.04M | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | $993.0K | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $6.73M | Apr 6, 2022 |
| FY2020 | Dec 31, 2019 | $3.88M | Mar 29, 2021 |
| FY2015 | Dec 31, 2015 | $9.99M | Mar 24, 2016 |
| FY2015 | Dec 31, 2014 | $11.37M | Mar 24, 2016 |
| FY2014 | Dec 31, 2013 | $14.28M | Mar 31, 2015 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Apr 6, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Mar 20, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | (1) | Mar 16, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Apr 6, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Mar 20, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | (1) | Mar 16, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 18.52M | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | 18.38M | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | 13.65M | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | 13.32M | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | 13.21M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | 12.15M | Apr 6, 2022 |
| FY2020 | Dec 31, 2019 | 12.12M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | 11.94M | Mar 20, 2020 |
| FY2018 | Dec 31, 2017 | 11.73M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | 11.67M | Mar 16, 2018 |